Live Breaking News & Updates on California Stock Down

Stay updated with breaking news from California stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Decheng Capital LLC Invests $28.85 Million in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Decheng Capital LLC Invests $28.85 Million in Pacific Biosciences of California, Inc. (NASDAQ:PACB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Davidw Meline , Pacific Biosciences , Decheng Capital , Quest Partners , Edmond De Rothschild Holding , Goldman Sachs Group , Hsbc Holdings , Dynamic Technology Lab Private Ltd , Us Bancorp , California Inc , Jpmorgan Chase Co , Free Report , Technology Lab Private Ltd , Director David , California Stock Down , Get Free Report , Visit Holdingschannel , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Sanfordc Bernstein , Pacific Biosciences , Oene Mark Van , Davidw Meline , Securities Exchange Commission , Advisor Group , California Company Profile , China Universal Asset Management Co , California Inc , Goldman Sachs Group , Interchange Capital Partners , Jpmorgan Chase Co , Get Free Report , California Stock Down , Exchange Commission , Director David , Funds Weigh In On Pacific Biosciences , Capital Partners , Financial Markets , Universal Asset Management , Kantonalbank Zurich Cantonalbank , California Company , California Daily ,

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00

The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Oene Mark Van , Pacific Biosciences , Davidw Meline , Wolfe Research , Goldman Sachs Group , Investment Management , California Inc , Pricet Rowe Associates Inc , Blackrock Inc , Vanguard Group Inc , Securities Exchange Commission , Capital International Investors , Get Free Report , California Stock Down , Exchange Commission , Director David , International Investors , Pricet Rowe Associates , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5%

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Pacific Biosciences , Davidw Meline , Christiano Henry , Vanguard Group Inc , California Inc , Capital International Investors , Pricet Rowe Associates Inc , California Company Profile , Blackrock Inc , Wolfe Research , Investment Management , Securities Exchange Commission , Get Free Report , California Stock Down , Director David , Exchange Commission , International Investors , Pricet Rowe Associates , California Company , California Daily ,

Insider Buying: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Acquires $176,000.00 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) Director David W. Meline purchased 40,000 shares of the stock in a transaction on Wednesday, March 6th. The stock was acquired at an average price of $4.40 per share, with a total value of $176,000.00. Following the acquisition, the director now directly owns 40,000 shares […] ....

United States , Davidw Meline , Pacific Biosciences , Comerica Bank , Securities Exchange Commission , Kayne Anderson Rudnick Investment Management , Fairfield Bush , California Company Profile , Wolfe Research , California Inc , Get Free Report , Director David , Exchange Commission , California Stock Down , Funds Weigh In On Pacific Biosciences , Financial Advisors , California Company , California Daily ,